These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 5160226)

  • 21. [Longtime study on the effects of L-dopa therapy in parkinsonism].
    Fischer PA; Schneider E; Jacobi P; Maxion H
    Nervenarzt; 1973 Mar; 44(3):128-35. PubMed ID: 4572536
    [No Abstract]   [Full Text] [Related]  

  • 22. [Parkinsonism and L-dopa: our 1st results].
    Warot P; Petit H; Chevalier-Lefebvre J; Herbaut G
    Lille Med; 1971 May; 16(5):765-7. PubMed ID: 5115349
    [No Abstract]   [Full Text] [Related]  

  • 23. [Action of L-dopa in Parkinson's syndrome].
    Ucar S; Eiras J
    Rev Clin Esp; 1971 Feb; 120(3):257-62. PubMed ID: 5568474
    [No Abstract]   [Full Text] [Related]  

  • 24. [L-dopa in Parkinson's syndrome].
    Filho RM; de Karam GM
    Rev Bras Med; 1971 May; 28(5):220-31. PubMed ID: 5563096
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of parkinsonism with levo-dopa: results in 302 cases.
    Newkirk TA; Magee KR
    Mich Med; 1971 Sep; 70(22):805-11. PubMed ID: 5141211
    [No Abstract]   [Full Text] [Related]  

  • 26. [Utility of L-dopa in the treatment of Parkinson's disease and parkinsonism-like diseases].
    Herskovits E; Matera R; Gacitua EF
    Medicina (B Aires); 1972; 32(1):10-4. PubMed ID: 5019629
    [No Abstract]   [Full Text] [Related]  

  • 27. [Study of 30 parkinsonian patients treated for 6 months with L-Dopa].
    Barbizet J; Duizabo P
    Therapie; 1972; 27(1):133-40. PubMed ID: 5017549
    [No Abstract]   [Full Text] [Related]  

  • 28. [Our first observations on Parkinson's disease or parkinsonian syndromes treated with L-dopa].
    Boudouresques J; Khalil R; Vigouroux RA; Gosset A; Daniel F; Dufour H
    Mars Med; 1971; 108(2):85-9. PubMed ID: 5548385
    [No Abstract]   [Full Text] [Related]  

  • 29. [L-DOPA therapy of parkinsonism].
    Refsum S
    Nord Med; 1969 May; 81(18):570-1. PubMed ID: 5768311
    [No Abstract]   [Full Text] [Related]  

  • 30. Paroxysmal hypertension during L-dopa treatment in parkinsonism: a metabolic error or a pharmacological effect?
    Barjon P; Fourcade J; Mimran A; Charra B
    Rev Eur Etud Clin Biol; 1972 Feb; 17(2):187-92. PubMed ID: 5055013
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of Parkinson syndromes with L-Dopa and the association of L-Dopa and a decarboxylase inhibitor].
    Guillard A
    Brux Med; 1972 Oct; 52(10):673-80. PubMed ID: 4656191
    [No Abstract]   [Full Text] [Related]  

  • 32. L-dopa and Parkinsonism.
    Lond Clin Med J; 1970 Jan; 11(1):5-7. PubMed ID: 5504130
    [No Abstract]   [Full Text] [Related]  

  • 33. L-dopa for Parkinsonism.
    Drug Ther Bull; 1969 Jul; 7(15):59-60. PubMed ID: 5806494
    [No Abstract]   [Full Text] [Related]  

  • 34. L-dopa in Parkinson's disease. A report on 95 cases and review of the literature.
    Lewis I
    J Med Assoc State Ala; 1971 May; 40(11):709-18. PubMed ID: 5573008
    [No Abstract]   [Full Text] [Related]  

  • 35. L-DOPA treatment for Parkinsonism: analysis of functional improvement.
    Jonas S
    Arch Phys Med Rehabil; 1971 Dec; 52(12):560-2. PubMed ID: 5136441
    [No Abstract]   [Full Text] [Related]  

  • 36. [L-DOPA administration in parkinsonism].
    Narabayashi H; Kosaka K
    Naika; 1971; 28(3):436-9. PubMed ID: 5097704
    [No Abstract]   [Full Text] [Related]  

  • 37. L-dopa treatment of parkinsonism. Clinical observations on the use of amantadine hydrochloride.
    Reveno WS; Bauer RB; Rosenbaum H
    Geriatrics; 1971 Aug; 26(8):61-70. PubMed ID: 5096462
    [No Abstract]   [Full Text] [Related]  

  • 38. Quantitative analysis of the effects of L-dopa on gait in 26 patients with Parkinsonism.
    Peterson CR; Calvert JC; Canzoneri J; Leavitt LA; McCutchen JJ; Schwartz L
    Am J Phys Med; 1972 Aug; 51(4):171-81. PubMed ID: 5052844
    [No Abstract]   [Full Text] [Related]  

  • 39. L-dopa: effect on highest integrative functions in Parkinsonism.
    Guthrie TC; Dunbar HS; Weider A
    Trans Am Neurol Assoc; 1970; 95():250-2. PubMed ID: 5514382
    [No Abstract]   [Full Text] [Related]  

  • 40. [L-Dopa therapy in Parkinson's disease. A double-blind study].
    Worm-Petersen J; Dupont E; Mikkelsen B
    Ugeskr Laeger; 1971 Nov; 133(47):2321-6. PubMed ID: 4944651
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.